Presented on March 15, 2024.
Join MDF for a Meet the Myotonic Dystrophy Drug Developers webinar with Avidity Biosciences! Don't miss this special presentation on the "Global Phase 3 HARBOR Study & Long-term MARINA-OLE Data". Click here to learn more about Avidity Biosciences.
Panelists include:
- Sarah Boyce, President & CEO, & Member of the Board of Directors, Avidity Biosciences
- Li-Jung Tai, MD, PhD, Executive Director in Clinical Development, Avidity Biosciences
- Kath Gallagher, Senior Vice President and Global Program Head, Myotonic Dystrophy Type 1, Avidity Biosciences
- John Day MD, PhD, Professor of Neurology, Pediatrics (Genetics) and Pathology, and Director of the Division of Neuromuscular Medicine, Stanford School of Medicine
About Meet the DM Drug Developers
Biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to find all our upcoming Meet the DM Drug Developers dates!
MDF Resources referenced in the Video: